Rafaèle Tordjman

Biography

 RafaeÌ€le Tordjman, MD, PhD, is a Managing Partner. She joined Sofinnova Partners in 2001. Prior to this, she worked as a research scientist at the Institut National de la Recherche Médicale (INSERM) in Cochin Hospital, Paris. Before joining INSERM, she was a medical doctor specializing in clinical haematology and internal medicine. She obtained her PhD, with high honours, in haematopoiesis and angiogenesis from the University Paris VII followed by a post doctoral fellowship in immunology. Rafaèle obtained her medical degree and her specialisation in Haematology and Internal Medicine as a five-year fellow in Paris University Hospitals. She also participated in the “Young Manager Program” at INSEAD (France, in 2002). She has invested in and is on the board of Ascendis, DBV technologies – which went public on Euronext Paris and on Nasdaq, Nucana Biomed, MedDay, ObsEva and Lysogene. She was also on the board of Corevalve, Endoart before it was successfully sold to Allergan Inc, of Preglem before the latter was successfully sold to Gedeon Richter, HBI Ltd before being acquired by Meda and off Flexion Therapeutics – which went public on Nasdaq.

Research Interest

 Research on Immunological Studies